Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

BACKGROUND: Patients with malignant mesothelioma have a poor prognosis and only 40% respond to first line treatment; a combination of pemetrexed and cisplatin or carboplatin. We used primary malignant mesothelioma cells and an ex vivo chemosensitivity assay with future purpose to predict best choice...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Szulkin, Adam, Ötvös, Rita, Hillerdal, Carl-Olof, Celep, Aytekin, Yousef-Fadhel, Eviane, Skribek, Henriette, Hjerpe, Anders, Székely, László, Dobra, Katalin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190467/
https://ncbi.nlm.nih.gov/pubmed/25253633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-709
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares